Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Apply
Cabozantinib, Nivolumab, Ipilimumab
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step